Bioprocessing of Viral Vaccines

Inbunden, Engelska, 2022

2 809 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This book focuses on cell culture-produced viral vaccines to meet the needs of the rapidly expanding research and development in academia and industry in the field. This book introduces the basic principles of vaccination and the manufacturing of viral vaccines. Bioprocessing of Viral Vaccines, will provide an overview of the advanced strategies needed to respond to the challenges of new and established viral infection diseases. The first few chapters cover the basics of virology and immunology as essential concepts to understand the function and design of viral vaccines. The core of the content is dedicated to process development, including upstream processing and cell culture of viral vaccines, downstream processing, and extensive analytical technologies specific to viral vaccines. Advanced process analytical technologies (PAT) and Quality by Design (QbD) concepts are also introduced in the context of vaccine manufacturing. The case studies included cover inactivated, attenuated vaccines exemplified by influenza vaccines, sub-unit vaccines exemplified by Virus Like Particles (VLPs: HPV vaccines) and sub-unit vaccines (Flublock), vectored vaccines: adenoviruses and Vesicular stomatitis Virus (VSV) vectored vaccines, genomic vaccines (DNA and mRNA) vaccines as developed for COVID-19 response in particular and a review of COVID-19 vaccines approved or in advanced clinical trials. This book is aimed at graduate engineers and professionals in the fields of vaccinology, bioprocessing, and biomanufacturing of viral vaccines.

Produktinformation

Utgivningsdatum2022-09-06
Mått156 x 234 x 26 mm
Vikt640 g
FormatInbunden
SpråkEngelska
Antal sidor320
FörlagTaylor & Francis Ltd
ISBN9781032132112

Tillhör följande kategorier

Onkologi inom Medicin
Biokemisk teknik inom Naturvetenskap och teknik
Biomedicinsk teknik inom Medicin
Biologi inom Naturvetenskap och teknik

Amine Kamen is a professor of bioengineering at McGill University, and CanadaResearch Chair in bioprocessing of viral vaccines. He is a researcher emeritus of theNational Research Council of Canada (NRC) where he was employed until early2014, as head of the Process Development section of the Human Health TherapeuticsPortfolio. At NRC, he established one of North America’s largest and most advancedgovernmental centers for animal cell culture addressing process development andscale-up of biologics. Also, he developed with his team and licensed to industrymultiple technology platforms for efficient manufacturing of recombinant proteinsand viral vectors and vaccines and led technology transfer to manufacturing sites forclinical evaluation and commercialization. His current research activities focus onuncovering mechanisms associated with cell production of viral vectors and viralvaccines, cell and metabolic engineering, process control and monitoring, and processanalytical technologies of high-yield productions of viral vectors for gene deliveryand vaccination. He has published over 170 papers in refereed international journalsand acts as a consultant for several national and international private and publicorganizations.Laura Cervera is a Chemical Engineer from Universitat Autònoma de Barcelona(Barcelona, Spain). After graduating she did her PhD in Biotechnology on the topic“Strategies for improving production levels of HIV-1 VLPs by transient transfectionof HEK 293 suspension cultures”. Then she moved to McGillUniversity (Montreal,Canada) to pursue her research on VLP production, this time using Insect cells as aplatform. She came back to Barcelona to join a project on AAV production for genetherapy applications using HEK 293 cells.

1. Bioprocessing of viral vaccines-Introduction. 2. Introduction to Virology. 3. Principles of immunology. 4. Cell lines for vaccine production. 5. Upstream Processing for Viral Vaccines – General Aspects. 6. Upstream Processing for Viral Vaccines - Process Intensification. 7. Downstream Processing of Viral Vaccines. 8. Analytical, QbD and PAT Applied to Viral Production Processes. 9. Manufacturing of seasonal and pandemic influenza vaccines - a case study. 10. Recombinant vaccines: Gag-based VLPs. 11. Vectored Vaccines. 12. Design and Production of Vaccines Against COVID-19 using Established Vaccine Platforms.